Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis

Background The combination of asthma and chronic obstructive pulmonary disease (COPD), or ACOS is a recently defined syndrome. The epidemiology of the condition is poorly described and previous research has suggested ACOS is associated with worse outcomes than either condition alone. We therefore decided to complete a systematic review of the published literature. Methods This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta- Analyses guidelines. A structured search was performed in the PubMed, Embase, and Medline databases up to Feb 2015 to identify studies reporting incidence, prevalence, health care utilization, morbidity, or mortality in COPD and asthma. Results A total of 19 studies were included in the present study. The pooled prevalence of overlap among COPD was 27% (95% CI: 0.16–0.38, p<0.0001) and 28% (95% CI: 0.09–0.47, p = 0.0032) in the population and hospital-based studies, respectively. We found no significant difference between ACOS and COPD in terms of gender, smoking status, lung function and 6mWD. However, in comparison to subject with only COPD, ACOS subjects were significantly younger, had higher BMI, healthcare utilization, and lower HRQoL. Conclusion ACOS is a common condition that exists in a substantial proportion of subjects with COPD. ACOS represents a distinct clinical phenotype with more frequent exacerbations, hospitalization, worse health-related quality of life, and higher healthcare costs than either disease alone. There is a critical need to better define the management and treatment of this syndrome.

[1]  J. Yim,et al.  Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. , 2014, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[2]  G. Valdivia,et al.  Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. , 2014, Chest.

[3]  P. Gibson,et al.  Systemic Inflammation in Older Adults With Asthma-COPD Overlap Syndrome , 2012, Allergy, asthma & immunology research.

[4]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[5]  A. Benfante The asthma-COPD overlap syndrome (ACOS): hype or reality? , 2014 .

[6]  T. Keistinen,et al.  High hospital burden in overlap syndrome of asthma and COPD , 2013, The clinical respiratory journal.

[7]  J. Soriano,et al.  Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. , 2013, Respiratory medicine.

[8]  R. de Marco,et al.  The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population , 2013, PloS one.

[9]  E. Antón,et al.  Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). , 2013, Respiratory medicine.

[10]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[11]  Joan B. Soriano,et al.  Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice , 2012, European Respiratory Journal.

[12]  A. Lindberg,et al.  COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies. , 2012, Respiratory medicine.

[13]  Christer Janson,et al.  The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden – the Burden of Obstructive Lung Disease (BOLD) study: cross‐sectional population‐based study , 2012, The clinical respiratory journal.

[14]  T. To,et al.  The course of asthma activity: a population study. , 2012, The Journal of allergy and clinical immunology.

[15]  M. Weatherall,et al.  Childhood asthma and GOLD‐defined chronic obstructive pulmonary disease , 2012, Internal medicine journal.

[16]  박용범,et al.  Medical Utilization and Cost in Patients with Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Asthma , 2012 .

[17]  D. Mannino,et al.  Asthma, Chronic Obstructive Pulmonary Disease, and Mortality in the U.S. Population , 2011, COPD.

[18]  Joyce D. Schroeder,et al.  The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.

[19]  T. Haahtela,et al.  Overlap Syndrome of Asthma and COPD Predicts Low Quality of Life , 2011, The Journal of asthma : official journal of the Association for the Care of Asthma.

[20]  P. Jousilahti,et al.  No increase in the prevalence of COPD in two decades , 2010, European Respiratory Journal.

[21]  N. Probst-Hensch,et al.  Prevalence of airflow obstruction in smokers and never-smokers in Switzerland , 2010, European Respiratory Journal.

[22]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[23]  P. Gibson,et al.  The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.

[24]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[25]  Jiachun Lu,et al.  COPD in Chinese nonsmokers , 2009, European Respiratory Journal.

[26]  A. Lindberg,et al.  A 20-Year Follow-Up of a Population Study-Based COPD Cohort-Report from the Obstructive Lung Disease in Northern Sweden Studies , 2009, COPD.

[27]  D. Mannino,et al.  COPD prevalence in southeastern Kentucky: the burden of lung disease study. , 2009, Chest.

[28]  M. Studnicka,et al.  Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study. , 2008, Respiratory medicine.

[29]  A L Hansell,et al.  Proportional classifications of COPD phenotypes , 2008, Thorax.

[30]  Anand A. Dalal,et al.  Burden of concomitant asthma and COPD in a Medicaid population. , 2008, Chest.

[31]  C. Blanchette,et al.  Economic Burden in Direct Costs of Concomitant Chronic Obstructive Pulmonary Disease and Asthma in a Medicare Advantage Population , 2008, Journal of managed care pharmacy : JMCP.

[32]  H. Magnussen,et al.  Improvements with tiotropium in COPD patients with concomitant asthma. , 2008, Respiratory medicine.

[33]  T. Seemungal,et al.  Chronic obstructive pulmonary disease is missed in asthmatics in specialty care in Trinidad, West Indies. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[34]  J. Soriano,et al.  Survival Among Copd Patients Using Fluticasone/Salmeterol in Combination Versus Other Inhaled Steroids and Bronchodilators Alone , 2007, COPD.

[35]  J. Panizza,et al.  Mortality and airflow obstruction in asthma: a 17‐year follow‐up study , 2006, Internal medicine journal.

[36]  R. West,et al.  Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample , 2006, Thorax.

[37]  Carolyn E Behrendt,et al.  Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. , 2005, Chest.

[38]  A. Gulsvik,et al.  Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[39]  F. Martinez,et al.  Is it asthma or COPD? , 2005, Postgraduate medicine.

[40]  B. Lundbäck,et al.  Chronic Obstructive Pulmonary Disease in Finland: Prevalence and Risk Factors , 2005, COPD.

[41]  Stefano Guerra,et al.  Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.

[42]  P. Jeffery Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[43]  Joan B Soriano,et al.  The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.

[44]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[45]  D. Mannino,et al.  Characteristics of adults dying with COPD. , 2002, Chest.

[46]  N. Pride,et al.  Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice , 2002, European Respiratory Journal.

[47]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[48]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .